Comorbid substance use disorder in schizophrenia: A selective overview of neurobiological and cognitive underpinnings

Psychiatry and Clinical Neurosciences - Tập 67 Số 6 - Trang 367-383 - 2013
Patrizia Thoma1, Irene Daum1
1Department of Neuropsychology, Institute of Cognitive Neuroscience, Ruhr University Bochum, Bochum, Germany

Tóm tắt

Although individuals with schizophrenia show a lifetime prevalence of 50% for suffering from a comorbid substance use disorder, substance abuse usually represents an exclusion criterion for studies on schizophrenia. This implies that surprisingly little is known about a large group of patients who are particularly difficult to treat. The aim of the present work is to provide a brief and non‐exhaustive overview of the current knowledgebase about neurobiological and cognitive underpinnings for dual diagnosis schizophrenia patients. Studies published within the last 20 years were considered using computerized search engines. The focus was on nicotine, caffeine, alcohol, cannabis and cocaine being among the most common substances of abuse. All drugs of abuse target dopaminergic, glutamatergic and GABAergic transmission which are also involved in the pathophysiology of schizophrenia. Current literature suggests that neurocognitive function might beless disrupted in substance‐abusing compared to non‐abusing schizophrenia patients, but in particular the neuroimaging database on this topic is sparse. Detrimental effects on brain structure and function were shown for patients for whom alcohol is the main substance of abuse. It is as yet unclear whether this finding might be an artifact of age differences of patient subgroups with different substance abuse patterns. More research is warranted on the specific neurocognitive underpinnings of schizophrenia patients abusing distinct psychoactive substances. Treatment programs might either benefit from preserved cognitive function as a resource or specifically target cognitive impairment in different subgroups of addicted schizophrenia patients.

Từ khóa


Tài liệu tham khảo

10.1001/jama.1990.03450190043026

10.1007/s00127-004-0713-0

10.1016/j.schres.2006.03.034

10.1097/00005053-198711000-00001

10.31887/DCNS.2006.8.1/bwinklbaur

10.1016/j.schres.2006.04.004

10.1192/bjp.bp.104.007237

10.1136/jnnp.2005.079228

10.1016/S0306-4603(98)00073-2

10.1017/S003329170500574X

Addington J, 1997, Substance abuse and cognitive functioning in schizophrenia, J. Psychiatry Neurosci., 22, 99

10.1001/archpsyc.63.5.490

10.1097/01.nmd.0000202575.79453.6e

10.1007/s00213-006-0413-4

10.1016/j.schres.2008.07.015

10.1007/s11126-009-9102-x

10.1093/schbul/sbp027

10.1093/schbul/sbq013

10.1192/bjp.bp.110.090175

10.2105/AJPH.86.7.973

10.1016/j.schres.2005.02.010

10.1176/ajp.152.3.453

10.1016/j.schres.2006.05.013

10.1016/j.schres.2006.04.022

10.1111/j.1600-0447.2009.01385.x

10.1093/schbul/sbp031

10.1111/j.1476-5381.2010.00721.x

10.1093/schbul/sbi027

10.1038/nature09563

10.1111/j.1465-3362.2009.00132.x

10.1016/j.schres.2010.03.037

10.1016/S0006-3223(01)01134-9

10.1093/schbul/sbm011

10.1093/oxfordjournals.schbul.a033339

10.3389/fpsyt.2010.00135

10.1176/appi.ajp.158.3.492

10.1038/sj.npp.1301207

10.1111/j.1600-0447.1997.tb09925.x

10.1017/S0033291700030324

10.1093/schbul/sbp016

10.1016/j.physbeh.2011.11.004

10.1055/s-0029-1216356

10.1176/appi.ajp.162.8.1483

10.1016/S0272-7358(99)00033-1

10.1146/annurev.ps.43.020192.001511

Green AI, 2007, Schizophrenia and co‐occurring substance use disorder, Am. J. Psychiatry, 164, 402, 10.1176/ajp.2007.164.3.402

10.3109/10673229709030550

10.1016/j.neubiorev.2005.02.006

10.1007/s11920-005-0082-8

10.1016/j.neuroimage.2005.07.051

10.1037/a0016166

10.1007/BF03033360

10.1016/j.biopsych.2009.09.006

Gouzoulis‐Mayfrank E, 2004, [Dual diagnosis of psychosis and addiction. From principles to practice], Nervenarzt, 75, 642

10.1111/j.1755-5949.2010.00144.x

10.1159/000110430

10.1007/s11920-004-0026-8

10.1007/BF03033359

10.2174/1874473710801020155

10.1016/j.neuroscience.2011.08.038

10.1016/S0149-7634(98)00050-5

10.1016/j.neubiorev.2005.04.016

10.1001/archpsyc.65.7.772

10.1038/sj.npp.1300558

10.1016/S0306-4522(00)00286-4

10.1523/JNEUROSCI.17-14-05327.1997

10.1016/j.neuroimage.2009.06.059

10.1093/cercor/bhj136

10.1016/S0925-4927(01)00104-4

10.1111/j.1749-6632.2009.05144.x

10.1016/j.schres.2007.08.019

10.1016/S0920-9964(98)00096-6

10.1016/j.schres.2011.05.014

10.1111/j.1440-1819.2007.01661.x

10.1001/archpsyc.57.9.894

10.1176/appi.ajp.160.6.1110

10.1001/archpsyc.60.3.245

10.1093/brain/awq153

10.1192/bjp.bp.106.024521

10.1097/YCO.0b013e3282f51266

10.1017/S146114571100068X

10.1016/j.schres.2011.02.014

10.1002/syn.10215

10.1016/j.euroneuro.2008.10.006

10.1016/j.euroneuro.2010.08.008

10.1176/appi.ajp.2007.07071110

10.1016/j.biopsych.2007.01.004

10.1016/S0376-8716(02)00110-2

10.1038/sj.npp.1301346

10.1016/j.biopsych.2005.09.004

10.1016/j.biopsych.2003.12.023

10.1093/schbul/sbp089

10.1016/j.schres.2008.06.008

10.1016/j.neuroimage.2007.12.040

10.3109/07853890009002029

10.4088/JCP.v67n0302

10.1080/17470910701376787

10.1111/j.1600-0447.2001.00452.x

10.1016/j.psc.2005.05.004

10.1016/j.pbb.2005.02.017

10.1016/S0166-2236(03)00065-1

10.1097/00019052-200312002-00007

10.1080/13546800802264330

Cleghorn JM, 1991, Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function, J. Clin. Psychiatry, 52, 26

Pencer A, 2003, Substance use and cognition in early psychosis, J. Psychiatry Neurosci., 28, 48

10.1016/0165-1781(96)02911-3

10.1016/j.bandc.2005.04.002

10.1097/01.NMD.0000066152.87832.A9

10.1111/j.1440-0979.2004.00346.x

10.1016/j.schres.2007.04.022

Norman DA, 1980, Attention to Action: Willed and Automatic Control of Behavior

10.1016/j.biopsych.2005.11.014

10.1016/j.tics.2005.02.008

10.1016/S0010-9452(08)70868-2

10.1093/acprof:oso/9780198524410.003.0002

10.1007/s00259-003-1382-z

10.1016/j.schres.2007.02.004

10.1111/j.1360-0443.2008.02156.x

10.1016/j.schres.2009.09.025

10.1093/oxfordjournals.schbul.a033320

10.1038/sj.npp.1301601

10.1016/S0006-3223(02)01342-2

10.1016/j.pnpbp.2004.01.002

10.1016/j.psychres.2011.05.037

10.1097/YCO.0b013e3283366643

10.1016/j.schres.2009.01.012

10.1016/j.schres.2007.07.030

10.1016/j.drugalcdep.2009.04.005

10.1016/B978-0-444-53817-8.00006-2

10.1093/jschbul/sbi001

Allen DN, 2001, Neuropsychological deficits in patients with schizophrenia and alcohol dependence, Arch. Clin. Neuropsychol., 15, 1762

10.1016/j.schres.2006.11.019

10.1016/j.schres.2009.05.020

10.1017/S1355617706060097

10.1093/alcalc/36.5.357

10.1016/j.pscychresns.2005.05.008

10.1523/JNEUROSCI.3446-08.2008

10.1037/0894-4105.13.1.62

10.1002/gps.1528

10.3389/neuro.09.053.2009

10.1080/00048670701634952

10.1016/j.schres.2010.04.007

10.1007/s00213-009-1512-9

10.1017/S0033291709992078

10.1016/j.schres.2011.02.017

Solowij N, 2007, Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?, J. Psychiatry Neurosci., 32, 30

10.1093/schbul/sbq079

10.1016/S0920-9964(02)00387-0

10.1016/j.schres.2010.08.017

10.1097/00005053-200203000-00010

10.1016/S0165-1781(99)00122-5

10.1016/S0899-3289(00)00021-3

10.1097/00005053-199010000-00005

10.1016/j.psychres.2004.07.006

10.1016/S0740-5472(02)00324-0

10.1080/10973439908408386

10.1097/NMD.0b013e3181b08bf4

10.1111/j.1521-0391.2011.00150.x

10.1097/NMD.0b013e3182214297

10.1016/j.pnpbp.2008.02.008

10.3109/09540261003689958

10.1016/j.eurpsy.2005.07.001

10.1176/appi.ajp.163.1.125

10.1016/S0920-9964(02)00292-X

10.1176/appi.ps.54.4.523

10.15288/jsa.1999.60.278

10.1080/00048670701579041

Thông tin
Thông tin xuất bản

Psychiatry and Clinical Neurosciences

Tập 67 Số 6

367-383

Thông tin tác giả